- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-6-6-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-MAN.2: 6 residues within 4Å:- Chain A: N.165, T.167, R.207
- Chain C: S.219, P.221, W.222
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:W.222
NAG-NAG-BMA-MAN.5: 5 residues within 4Å:- Chain A: S.219, P.221, W.222
- Chain B: N.165, T.167
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:T.167
- Hydrogen bonds: A:W.222
NAG-NAG-BMA-MAN.7: 5 residues within 4Å:- Chain B: S.219, P.221, W.222
- Chain C: N.165, T.167
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:W.222
NAG-NAG-BMA-MAN.15: 6 residues within 4Å:- Chain D: N.165, T.167, R.207
- Chain F: S.219, P.221, W.222
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:W.222
NAG-NAG-BMA-MAN.18: 5 residues within 4Å:- Chain D: S.219, P.221, W.222
- Chain E: N.165, T.167
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain D- Hydrophobic interactions: E:T.167
- Hydrogen bonds: D:W.222
NAG-NAG-BMA-MAN.20: 5 residues within 4Å:- Chain E: S.219, P.221, W.222
- Chain F: N.165, T.167
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:W.222
- 4 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose(Non-covalent)
GAL-SIA.4: 11 residues within 4Å:- Chain A: Y.98, G.134, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.153, A:T.155
- Hydrogen bonds: A:Y.98, A:G.135, A:S.137, A:E.190, A:Q.226
GAL-SIA.6: 11 residues within 4Å:- Chain B: Y.98, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226, G.228
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:Q.226, B:Y.98, B:G.135, B:S.136, B:S.136, B:S.137, B:E.190, B:Q.226, B:G.228
- Hydrophobic interactions: B:W.153, B:T.155
GAL-SIA.17: 11 residues within 4Å:- Chain D: Y.98, G.134, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:W.153, D:T.155
- Hydrogen bonds: D:G.135, D:S.137, D:E.190, D:Q.226
GAL-SIA.19: 11 residues within 4Å:- Chain E: Y.98, G.135, S.136, S.137, W.153, T.155, H.183, E.190, L.194, Q.226, G.228
9 PLIP interactions:9 interactions with chain E- Hydrogen bonds: E:Q.226, E:G.135, E:S.136, E:S.136, E:S.137, E:E.190, E:Q.226, E:G.228
- Hydrophobic interactions: E:W.153, E:T.155
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 2 residues within 4Å:- Chain A: N.38, T.318
Ligand excluded by PLIPNAG.9: 2 residues within 4Å:- Chain B: N.38, T.318
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain B: N.81, F.120, I.121
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain C: T.24, N.38, A.39
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain C: Q.80, N.81, E.119, F.120
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain C: N.285, V.297, N.298
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain D: N.38, T.318
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain E: N.38, T.318
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain E: N.81, F.120, I.121
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain F: T.24, N.38, A.39
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain F: Q.80, N.81, E.119, F.120
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain F: N.285, V.297, N.298
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain G: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain H: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain I: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain J: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain K: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain L: A.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ha, Y. et al., X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology (2003)
- Release Date
- 2003-08-26
- Peptides
- Hemagglutinin HA1 chain: ABCDEF
Hemagglutinin HA2 chain: GHIJKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
GD
AE
DF
GG
BH
EI
HJ
BK
EL
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-6-6-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose(Non-covalent)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ha, Y. et al., X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology (2003)
- Release Date
- 2003-08-26
- Peptides
- Hemagglutinin HA1 chain: ABCDEF
Hemagglutinin HA2 chain: GHIJKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
DC
GD
AE
DF
GG
BH
EI
HJ
BK
EL
H